Certified Neuroscience Registered Nurse (CNRN) Practice Exam

When treating spasticity in patients with syringomyelia, what should be balanced to avoid complications?

1. Patient comfort and efficacy of medication

2. Reduction of spasticity and muscle strength

3. Inadvertently increasing weakness

4. Medication dosage and side effects

The correct answer is: Inadvertently increasing weakness

The correct choice emphasizes the importance of not inadvertently increasing weakness while treating spasticity in patients with syringomyelia. It is crucial in the management of spasticity to ensure that muscle strength is preserved, as excessive reduction of spasticity can lead to a decrease in muscle tone that is sometimes compensatory, especially in patients with chronic conditions like syringomyelia. If spasticity is overly reduced, patients may experience increased weakness, which can adversely affect their mobility and quality of life. Patients with syringomyelia often have a delicate balance between managing spasticity for improved function and maintaining sufficient muscle strength for mobility and stability. It is essential for healthcare providers to carefully assess and monitor treatment interventions, aiming to relieve spasticity without causing an undue decrease in muscle strength, thereby avoiding complications that could negatively impact patient outcomes. Balancing these factors requires a thorough understanding of the patient's overall condition and history, allowing for a tailored approach to treatment that minimizes risks while addressing symptoms effectively.